The association between the cystatin C- and creatinine-based estimated GFR ratio and post-ablation outcomes in patients with atrial fibrillation [0.03%]
胱抑素C和肌酐估计GFR比例与房颤消融预后的关系研究
Wenchao Huang,Luxiang Shang,Yan Luo et al.
Wenchao Huang et al.
Background: The difference between the cystatin C-based eGFR (eGFRcys) and the creatinine-based eGFR (eGFRcr) is associated with the risk of developing atrial fibrillation (AF) risk. However, its impact on AF ablation out...
Quality indicators and clinical outcomes: the role of care quality in nondiabetic chronic kidney disease management [0.03%]
质量指标和临床结局：非糖尿病性慢性肾病管理中护理质量的作用
Yun-Fang Hsieh,Le-Yin Hsu,Ping-Hsiu Tsai et al.
Yun-Fang Hsieh et al.
Quality indicators (QIs) are essential for evaluating healthcare quality, but their validation for nondiabetic chronic kidney disease (CKD) populations is limited. We aimed to assess the association between QIs and outcomes in nondiabetic C...
The clinical outcomes of acute kidney injury substages based on serum cystatin C in pediatric patients undergoing cardiac surgery [0.03%]
基于血清胱抑素C的急性肾损伤亚分期对心脏手术患儿的临床预后影响研究
Yinan Li,Dongyun Bie,Chao Xiong et al.
Yinan Li et al.
Background: Multiple biomarkers have been identified by previous studies to diagnose acute kidney injury (AKI). The combination of biomarkers with conventional criteria to define AKI substages in order to identify high-ri...
Brain natriuretic peptide is a biomarker of atrial fibrillation in hemodialysis patients [0.03%]
脑钠肽是血液透析患者房颤的生物标志物
Ling Yu,Jia Huang,Yanchun Li et al.
Ling Yu et al.
Objectives: Atrial fibrillation (AF) is the most common persistent arrhythmia and has adverse outcomes in hemodialysis patients. It is obscure the relationship between BNP and AF in hemodialysis patients. This study inves...
Observational Study
Renal failure. 2025 Dec;47(1):2463563. DOI:10.1080/0886022X.2025.2463563 2025
Nafamostat mesylate versus regional citrate anticoagulation for chronic hemodialysis in patients at high risk of bleeding: a single-center, retrospective study [0.03%]
那法莫司特硫酸盐与区域枸橼酸抗凝在高出血风险慢性血透患者中的应用：单中心回顾性研究
Jiangtao Li,Lirui Wang,Yuqiu Lu et al.
Jiangtao Li et al.
Introduction: For hemodialysis patients at high risk of bleeding, a regional anticoagulant can be used, such as citrate or nafamostat mesylate (NM). The objective of this study was to evaluate NM as an alternative to citr...
Comparative Study
Renal failure. 2025 Dec;47(1):2464830. DOI:10.1080/0886022X.2025.2464830 2025
Prognosis of critically ill patients with early and late sepsis-associated acute kidney injury: an observational study based on the MIMIC-IV [0.03%]
早期和晚期脓毒症相关急性肾损伤的危重患者的预后：基于MIMIC-IV的观察研究
Bowen Shi,Jianfeng Ye,Weisheng Chen et al.
Bowen Shi et al.
Objective: The Acute Disease Quality Initiative (ADQI) working group recently released a consensus definition of sepsis-associated acute kidney injury (SA-AKI), but the prognosis and risk factors for early and late SA-AKI...
Observational Study
Renal failure. 2025 Dec;47(1):2441393. DOI:10.1080/0886022X.2024.2441393 2025
Comparison of the patency rates of catheter placement via the right external jugular vein route versus the right brachiocephalic vein route in patients experiencing tunneled-cuffed catheter loss [0.03%]
右外侧颈静脉与右头臂静脉导管置入在长时间使用带隧道和瓣膜的导管丢失病人的通畅率比较研究
Jun Yin,Fengping Wang
Jun Yin
Introduction: The aim of this study is to compare the patency rates of catheter placement via cannulation of right external jugular vein (EJV) versus the right brachiocephalic (BCV) in patients experiencing tunneled-cuffe...
Comparative Study
Renal failure. 2025 Dec;47(1):2457516. DOI:10.1080/0886022X.2025.2457516 2025
Evaluating the efficacy of basiliximab versus no induction in low-immunological-risk kidney transplant recipients: a propensity score matched analysis [0.03%]
评估在低免疫风险的肾移植受者中巴利西单抗与不使用诱导治疗的疗效：倾向性评分匹配分析
Dahao Zhang,Jiqiu Wen,Jianhui Dong et al.
Dahao Zhang et al.
Background: The optimal use of induction therapy in low-immunological-risk kidney transplant recipients (KTRs) remains uncertain. While Basiliximab (BSX) is widely utilized, its comparative outcomes with no induction ther...
Comparative Study
Renal failure. 2025 Dec;47(1):2460729. DOI:10.1080/0886022X.2025.2460729 2025
The triglyceride-glucose index and acute kidney injury risk in critically ill patients with coronary artery disease [0.03%]
甘油三酯-葡萄糖指数与冠状动脉疾病重症患者急性肾损伤风险的关系
Yi Zhang,Gang Li,Junjie Li et al.
Yi Zhang et al.
Background: The triglyceride-glucose (TyG) index, proven a reliable and simple surrogate of insulin resistance, has shown potential associations with cardiovascular outcomes and renal diseases. This research delved into t...
Safety and tolerability of molnupiravir and nirmatrelvir/ritonavir in patients with advanced chronic kidney disease and kidney failure; a cohort study [0.03%]
患有晚期慢性肾病和肾衰竭的患者使用molnupiravir和nirmatrelvir/ritonavir的安全性和耐受性：队列研究
Rani Sawtell,Tianqi Ouyang,Daiana Moreno et al.
Rani Sawtell et al.
Patients with advanced chronic kidney disease (CKD) and kidney failure were excluded from clinical trials that led to approval of molnupiravir and nirmatrelvir/ritonavir for COVID-19. Between November 2022 and February 2024 there were 100 p...